Report Detail

Pharma & Healthcare Global Vaccine Excipients Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

  • RnM4546524
  • |
  • 02 August, 2023
  • |
  • Global
  • |
  • 118 Pages
  • |
  • GIR (Global Info Research)
  • |
  • Pharma & Healthcare

According to our (Global Info Research) latest study, the global Vaccine Excipients market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period.
The manufacture and composition of vaccines are complex and are strictly regulated to maximize potency and safety. In addition to antigens, vaccines also contain some important substances—vaccine excipients. Vaccine excipients comprise all chemical compounds used in the production of vaccines, such as vaccine stabilizers, vaccine emulsifiers, preservatives and vaccine adjuvants.
The Global Info Research report includes an overview of the development of the Vaccine Excipients industry chain, the market status of Research Applications (Vaccine Stabilizers, Vaccine Emulsifiers), Commercial Applications (Vaccine Stabilizers, Vaccine Emulsifiers), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Vaccine Excipients.
Regionally, the report analyzes the Vaccine Excipients markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Vaccine Excipients market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Vaccine Excipients market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Vaccine Excipients industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (kg), revenue generated, and market share of different by Type (e.g., Vaccine Stabilizers, Vaccine Emulsifiers).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Vaccine Excipients market.
Regional Analysis: The report involves examining the Vaccine Excipients market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Vaccine Excipients market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Vaccine Excipients:
Company Analysis: Report covers individual Vaccine Excipients manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Vaccine Excipients This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Research Applications, Commercial Applications).
Technology Analysis: Report covers specific technologies relevant to Vaccine Excipients. It assesses the current state, advancements, and potential future developments in Vaccine Excipients areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Vaccine Excipients market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Vaccine Excipients market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Vaccine Stabilizers
Vaccine Emulsifiers
Vaccine Adjuvants
Preservatives
Market segment by Application
Research Applications
Commercial Applications
Major players covered
Curia
Croda Pharma
Alfa Chemistry
A & C
Avantor
GS
SEPPIC
Novavax
Dynavax Technologies
Sanofi
Zhifei Biological
Escon
Rico Bio
CSL Limited
Creative Biolabs
Central Drug House
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Vaccine Excipients product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Vaccine Excipients, with price, sales, revenue and global market share of Vaccine Excipients from 2018 to 2023.
Chapter 3, the Vaccine Excipients competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Vaccine Excipients breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Vaccine Excipients market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Vaccine Excipients.
Chapter 14 and 15, to describe Vaccine Excipients sales channel, distributors, customers, research findings and conclusion.


1 Market Overview

  • 1.1 Product Overview and Scope of Vaccine Excipients
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Market Analysis by Type
    • 1.3.1 Overview: Global Vaccine Excipients Consumption Value by Type: 2018 Versus 2022 Versus 2029
    • 1.3.2 Vaccine Stabilizers
    • 1.3.3 Vaccine Emulsifiers
    • 1.3.4 Vaccine Adjuvants
    • 1.3.5 Preservatives
  • 1.4 Market Analysis by Application
    • 1.4.1 Overview: Global Vaccine Excipients Consumption Value by Application: 2018 Versus 2022 Versus 2029
    • 1.4.2 Research Applications
    • 1.4.3 Commercial Applications
  • 1.5 Global Vaccine Excipients Market Size & Forecast
    • 1.5.1 Global Vaccine Excipients Consumption Value (2018 & 2022 & 2029)
    • 1.5.2 Global Vaccine Excipients Sales Quantity (2018-2029)
    • 1.5.3 Global Vaccine Excipients Average Price (2018-2029)

2 Manufacturers Profiles

  • 2.1 Curia
    • 2.1.1 Curia Details
    • 2.1.2 Curia Major Business
    • 2.1.3 Curia Vaccine Excipients Product and Services
    • 2.1.4 Curia Vaccine Excipients Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.1.5 Curia Recent Developments/Updates
  • 2.2 Croda Pharma
    • 2.2.1 Croda Pharma Details
    • 2.2.2 Croda Pharma Major Business
    • 2.2.3 Croda Pharma Vaccine Excipients Product and Services
    • 2.2.4 Croda Pharma Vaccine Excipients Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.2.5 Croda Pharma Recent Developments/Updates
  • 2.3 Alfa Chemistry
    • 2.3.1 Alfa Chemistry Details
    • 2.3.2 Alfa Chemistry Major Business
    • 2.3.3 Alfa Chemistry Vaccine Excipients Product and Services
    • 2.3.4 Alfa Chemistry Vaccine Excipients Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.3.5 Alfa Chemistry Recent Developments/Updates
  • 2.4 A & C
    • 2.4.1 A & C Details
    • 2.4.2 A & C Major Business
    • 2.4.3 A & C Vaccine Excipients Product and Services
    • 2.4.4 A & C Vaccine Excipients Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.4.5 A & C Recent Developments/Updates
  • 2.5 Avantor
    • 2.5.1 Avantor Details
    • 2.5.2 Avantor Major Business
    • 2.5.3 Avantor Vaccine Excipients Product and Services
    • 2.5.4 Avantor Vaccine Excipients Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.5.5 Avantor Recent Developments/Updates
  • 2.6 GS
    • 2.6.1 GS Details
    • 2.6.2 GS Major Business
    • 2.6.3 GS Vaccine Excipients Product and Services
    • 2.6.4 GS Vaccine Excipients Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.6.5 GS Recent Developments/Updates
  • 2.7 SEPPIC
    • 2.7.1 SEPPIC Details
    • 2.7.2 SEPPIC Major Business
    • 2.7.3 SEPPIC Vaccine Excipients Product and Services
    • 2.7.4 SEPPIC Vaccine Excipients Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.7.5 SEPPIC Recent Developments/Updates
  • 2.8 Novavax
    • 2.8.1 Novavax Details
    • 2.8.2 Novavax Major Business
    • 2.8.3 Novavax Vaccine Excipients Product and Services
    • 2.8.4 Novavax Vaccine Excipients Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.8.5 Novavax Recent Developments/Updates
  • 2.9 Dynavax Technologies
    • 2.9.1 Dynavax Technologies Details
    • 2.9.2 Dynavax Technologies Major Business
    • 2.9.3 Dynavax Technologies Vaccine Excipients Product and Services
    • 2.9.4 Dynavax Technologies Vaccine Excipients Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.9.5 Dynavax Technologies Recent Developments/Updates
  • 2.10 Sanofi
    • 2.10.1 Sanofi Details
    • 2.10.2 Sanofi Major Business
    • 2.10.3 Sanofi Vaccine Excipients Product and Services
    • 2.10.4 Sanofi Vaccine Excipients Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.10.5 Sanofi Recent Developments/Updates
  • 2.11 Zhifei Biological
    • 2.11.1 Zhifei Biological Details
    • 2.11.2 Zhifei Biological Major Business
    • 2.11.3 Zhifei Biological Vaccine Excipients Product and Services
    • 2.11.4 Zhifei Biological Vaccine Excipients Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.11.5 Zhifei Biological Recent Developments/Updates
  • 2.12 Escon
    • 2.12.1 Escon Details
    • 2.12.2 Escon Major Business
    • 2.12.3 Escon Vaccine Excipients Product and Services
    • 2.12.4 Escon Vaccine Excipients Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.12.5 Escon Recent Developments/Updates
  • 2.13 Rico Bio
    • 2.13.1 Rico Bio Details
    • 2.13.2 Rico Bio Major Business
    • 2.13.3 Rico Bio Vaccine Excipients Product and Services
    • 2.13.4 Rico Bio Vaccine Excipients Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.13.5 Rico Bio Recent Developments/Updates
  • 2.14 CSL Limited
    • 2.14.1 CSL Limited Details
    • 2.14.2 CSL Limited Major Business
    • 2.14.3 CSL Limited Vaccine Excipients Product and Services
    • 2.14.4 CSL Limited Vaccine Excipients Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.14.5 CSL Limited Recent Developments/Updates
  • 2.15 Creative Biolabs
    • 2.15.1 Creative Biolabs Details
    • 2.15.2 Creative Biolabs Major Business
    • 2.15.3 Creative Biolabs Vaccine Excipients Product and Services
    • 2.15.4 Creative Biolabs Vaccine Excipients Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.15.5 Creative Biolabs Recent Developments/Updates
  • 2.16 Central Drug House
    • 2.16.1 Central Drug House Details
    • 2.16.2 Central Drug House Major Business
    • 2.16.3 Central Drug House Vaccine Excipients Product and Services
    • 2.16.4 Central Drug House Vaccine Excipients Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
    • 2.16.5 Central Drug House Recent Developments/Updates

3 Competitive Environment: Vaccine Excipients by Manufacturer

  • 3.1 Global Vaccine Excipients Sales Quantity by Manufacturer (2018-2023)
  • 3.2 Global Vaccine Excipients Revenue by Manufacturer (2018-2023)
  • 3.3 Global Vaccine Excipients Average Price by Manufacturer (2018-2023)
  • 3.4 Market Share Analysis (2022)
    • 3.4.1 Producer Shipments of Vaccine Excipients by Manufacturer Revenue ($MM) and Market Share (%): 2022
    • 3.4.2 Top 3 Vaccine Excipients Manufacturer Market Share in 2022
    • 3.4.2 Top 6 Vaccine Excipients Manufacturer Market Share in 2022
  • 3.5 Vaccine Excipients Market: Overall Company Footprint Analysis
    • 3.5.1 Vaccine Excipients Market: Region Footprint
    • 3.5.2 Vaccine Excipients Market: Company Product Type Footprint
    • 3.5.3 Vaccine Excipients Market: Company Product Application Footprint
  • 3.6 New Market Entrants and Barriers to Market Entry
  • 3.7 Mergers, Acquisition, Agreements, and Collaborations

4 Consumption Analysis by Region

  • 4.1 Global Vaccine Excipients Market Size by Region
    • 4.1.1 Global Vaccine Excipients Sales Quantity by Region (2018-2029)
    • 4.1.2 Global Vaccine Excipients Consumption Value by Region (2018-2029)
    • 4.1.3 Global Vaccine Excipients Average Price by Region (2018-2029)
  • 4.2 North America Vaccine Excipients Consumption Value (2018-2029)
  • 4.3 Europe Vaccine Excipients Consumption Value (2018-2029)
  • 4.4 Asia-Pacific Vaccine Excipients Consumption Value (2018-2029)
  • 4.5 South America Vaccine Excipients Consumption Value (2018-2029)
  • 4.6 Middle East and Africa Vaccine Excipients Consumption Value (2018-2029)

5 Market Segment by Type

  • 5.1 Global Vaccine Excipients Sales Quantity by Type (2018-2029)
  • 5.2 Global Vaccine Excipients Consumption Value by Type (2018-2029)
  • 5.3 Global Vaccine Excipients Average Price by Type (2018-2029)

6 Market Segment by Application

  • 6.1 Global Vaccine Excipients Sales Quantity by Application (2018-2029)
  • 6.2 Global Vaccine Excipients Consumption Value by Application (2018-2029)
  • 6.3 Global Vaccine Excipients Average Price by Application (2018-2029)

7 North America

  • 7.1 North America Vaccine Excipients Sales Quantity by Type (2018-2029)
  • 7.2 North America Vaccine Excipients Sales Quantity by Application (2018-2029)
  • 7.3 North America Vaccine Excipients Market Size by Country
    • 7.3.1 North America Vaccine Excipients Sales Quantity by Country (2018-2029)
    • 7.3.2 North America Vaccine Excipients Consumption Value by Country (2018-2029)
    • 7.3.3 United States Market Size and Forecast (2018-2029)
    • 7.3.4 Canada Market Size and Forecast (2018-2029)
    • 7.3.5 Mexico Market Size and Forecast (2018-2029)

8 Europe

  • 8.1 Europe Vaccine Excipients Sales Quantity by Type (2018-2029)
  • 8.2 Europe Vaccine Excipients Sales Quantity by Application (2018-2029)
  • 8.3 Europe Vaccine Excipients Market Size by Country
    • 8.3.1 Europe Vaccine Excipients Sales Quantity by Country (2018-2029)
    • 8.3.2 Europe Vaccine Excipients Consumption Value by Country (2018-2029)
    • 8.3.3 Germany Market Size and Forecast (2018-2029)
    • 8.3.4 France Market Size and Forecast (2018-2029)
    • 8.3.5 United Kingdom Market Size and Forecast (2018-2029)
    • 8.3.6 Russia Market Size and Forecast (2018-2029)
    • 8.3.7 Italy Market Size and Forecast (2018-2029)

9 Asia-Pacific

  • 9.1 Asia-Pacific Vaccine Excipients Sales Quantity by Type (2018-2029)
  • 9.2 Asia-Pacific Vaccine Excipients Sales Quantity by Application (2018-2029)
  • 9.3 Asia-Pacific Vaccine Excipients Market Size by Region
    • 9.3.1 Asia-Pacific Vaccine Excipients Sales Quantity by Region (2018-2029)
    • 9.3.2 Asia-Pacific Vaccine Excipients Consumption Value by Region (2018-2029)
    • 9.3.3 China Market Size and Forecast (2018-2029)
    • 9.3.4 Japan Market Size and Forecast (2018-2029)
    • 9.3.5 Korea Market Size and Forecast (2018-2029)
    • 9.3.6 India Market Size and Forecast (2018-2029)
    • 9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
    • 9.3.8 Australia Market Size and Forecast (2018-2029)

10 South America

  • 10.1 South America Vaccine Excipients Sales Quantity by Type (2018-2029)
  • 10.2 South America Vaccine Excipients Sales Quantity by Application (2018-2029)
  • 10.3 South America Vaccine Excipients Market Size by Country
    • 10.3.1 South America Vaccine Excipients Sales Quantity by Country (2018-2029)
    • 10.3.2 South America Vaccine Excipients Consumption Value by Country (2018-2029)
    • 10.3.3 Brazil Market Size and Forecast (2018-2029)
    • 10.3.4 Argentina Market Size and Forecast (2018-2029)

11 Middle East & Africa

  • 11.1 Middle East & Africa Vaccine Excipients Sales Quantity by Type (2018-2029)
  • 11.2 Middle East & Africa Vaccine Excipients Sales Quantity by Application (2018-2029)
  • 11.3 Middle East & Africa Vaccine Excipients Market Size by Country
    • 11.3.1 Middle East & Africa Vaccine Excipients Sales Quantity by Country (2018-2029)
    • 11.3.2 Middle East & Africa Vaccine Excipients Consumption Value by Country (2018-2029)
    • 11.3.3 Turkey Market Size and Forecast (2018-2029)
    • 11.3.4 Egypt Market Size and Forecast (2018-2029)
    • 11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
    • 11.3.6 South Africa Market Size and Forecast (2018-2029)

12 Market Dynamics

  • 12.1 Vaccine Excipients Market Drivers
  • 12.2 Vaccine Excipients Market Restraints
  • 12.3 Vaccine Excipients Trends Analysis
  • 12.4 Porters Five Forces Analysis
    • 12.4.1 Threat of New Entrants
    • 12.4.2 Bargaining Power of Suppliers
    • 12.4.3 Bargaining Power of Buyers
    • 12.4.4 Threat of Substitutes
    • 12.4.5 Competitive Rivalry
  • 12.5 Influence of COVID-19 and Russia-Ukraine War
    • 12.5.1 Influence of COVID-19
    • 12.5.2 Influence of Russia-Ukraine War

13 Raw Material and Industry Chain

  • 13.1 Raw Material of Vaccine Excipients and Key Manufacturers
  • 13.2 Manufacturing Costs Percentage of Vaccine Excipients
  • 13.3 Vaccine Excipients Production Process
  • 13.4 Vaccine Excipients Industrial Chain

14 Shipments by Distribution Channel

  • 14.1 Sales Channel
    • 14.1.1 Direct to End-User
    • 14.1.2 Distributors
  • 14.2 Vaccine Excipients Typical Distributors
  • 14.3 Vaccine Excipients Typical Customers

15 Research Findings and Conclusion

    16 Appendix

    • 16.1 Methodology
    • 16.2 Research Process and Data Source

    Summary:
    Get latest Market Research Reports on Vaccine Excipients. Industry analysis & Market Report on Vaccine Excipients is a syndicated market report, published as Global Vaccine Excipients Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Vaccine Excipients market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

    Last updated on

    REPORT YOU MIGHT BE INTERESTED

    Purchase this Report

    $3,480.00
    $5,220.00
    $6,960.00
    2,690.04
    4,035.06
    5,380.08
    3,239.88
    4,859.82
    6,479.76
    531,361.20
    797,041.80
    1,062,722.40
    293,712.00
    440,568.00
    587,424.00
    Credit card Logo

    Related Reports


    Reason to Buy

    Request for Sample of this report